- Aerobiotix, a Miamisburg, Ohio-based global medical company, raised $25m in equity financing
- The round was led by Vivo Capital with participation from Asahi Kasei Ventures
- The company also intends to use the funds to accelerate sales, marketing, and new product development
- Aerobiotix also makes airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long term care and office based settings
- The company’s infection control products have used to support thousands of procedures across multiple surgical specialty disciplines and in over 175 hospitals and multiple long-term care facilities
- Aerobiotix has developed a novel suite of FDA 510(k) cleared hospital-based air decontamination products and its devices supported by multiple peer-reviewed research studies
